BioSpace News Archive

Wilmington, Delaware, United States, Transparency Market Research Inc. – In recent period, the major population from all across the world is inclined toward the use of traditional Chinese medicines.

Calgary, Alberta--(Newsfile Corp. - August 19, 2022) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) (“Hemostemix” or the “Company”) is pleased to announce a non-brokered private placement of up to five Million Units priced at $0.30 each, closing in tranches.

Wilmington, Delaware, United States, Transparency Market Research Inc. – Proton therapy, also called proton radiotherapy, utilizes high-energy beam to treat tumors.

Wilmington, Delaware, United States, Transparency Market Research Inc. – The players and drug developers working in the landscape of the pharmaceutical industry are nowadays increasingly focusing on outsourcing their production and manufacturing capabilities.

Skye Bioscience, Inc. (OTCQB: SKYE) (“Skye” or the “Company”), reports that the shareholders of Emerald Health Therapeutics, Inc. (“Emerald” or the “Company”) (CSE: EMH; OTCQB: EMHTF) today approved the proposed plan of arrangement (the “Arrangement”) with Skye, with approval by 87.07% of votes cast by shareholders for that resolution.

Kala Pharmaceuticals, Inc., announced that the Company granted non-statutory stock options to new employees as an inducement award outside the Company’s 2017 Equity Incentive Plan in accordance with NASDAQ Listing Rule 5635.

Sutro Biopharma, Inc., a clinical-stage oncology company pioneering site-specific and novel-format antibody drug conjugates, announced that on August 16, 2022, the Compensation Committee of Sutro’s Board of Directors granted 63,000 Restricted Stock Units of Sutro common stock to three new employees.

Senti Biosciences, Inc. announced that on August 18, 2022, the compensation committee of Senti Bio’s board of directors granted to thirty five new employees stock options to purchase an aggregate of 421,659 shares of the Company’s common stock with a per share exercise price of $1.99.

Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global biotechnology company developing, manufacturing and commercializing novel therapies to treat life-threatening diseases, today announced its participation in the upcoming investor conferences.

Novavax, Inc. announced that the Novavax COVID-19 Vaccine, Adjuvanted has received expanded emergency use authorization from the U.S. Food and Drug Administration to provide a two-dose primary series for active immunization to prevent coronavirus disease 2019 caused by severe acute respiratory syndrome coronavirus 2 in adolescents aged 12 through 17.